Related Experiment Video
Updated: Aug 7, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
On the mechanism of action of antiarrhythmic agents
1Department of Medicine, Duke University Medical Center, Durham, NC 27706.
Insights
Cardiac arrhythmias stem from ion channel dysfunction. Antiarrhythmic drugs target sodium, potassium, and calcium channels to restore normal heart rhythm by blocking these channels.
Area of Science:
- Cardiology
- Pharmacology
- Molecular Biology
Background:
- Cardiac arrhythmias originate from disruptions in ion channel function or expression.
- Reentrant arrhythmias constitute the most prevalent clinically significant type.
- Depressed sodium channel function is a common cause of arrhythmias.
Purpose of the Study:
- To elucidate the mechanisms of action of antiarrhythmic agents.
- To correlate drug actions with the underlying cellular mechanisms of cardiac arrhythmias.
Main Methods:
- Review of antiarrhythmic drug classes (I, III, IV).
- Analysis of ion channel blockade and its effects on cardiac action potentials.
- Discussion of drug interactions with sodium, potassium, and calcium channels.
Main Results:
- Class I agents (local anesthetics) slow conduction by blocking sodium channels.
- Class III agents prolong action potential duration, impacting repolarization.
- Class IV agents (calcium channel blockers) are effective for reentrant arrhythmias sustained by calcium currents.
Conclusions:
- No single antiarrhythmic agent exhibits exclusive action on one ion channel type.
- Understanding ion channel function is crucial for managing cardiac arrhythmias.
- Drug mechanisms are directly linked to the cellular basis of arrhythmia generation.
Abstract:
Cardiac arrhythmias arise from disturbances in the functioning of the specific ion channels that normally control excitation or from the functional expression of previously latent channels. Antiarrhythmic agents act by blocking the membrane sodium, potassium, and calcium channels, but no agent has exclusive action on a given type of channel. Arrhythmias resulting from reentry form the largest group of clinically significant arrhythmias. Most arrhythmias result from depressed sodium channel function. The local anesthetic class of sodium channel blockers (class I agents) acts by slowing conduction and converting regions of unidirectional block to bidirectional block. Class III agents act by prolonging the action potential duration. Because potassium currents are normally responsible for repolarization of the cardiac action potentials, these agents are generally assumed to be potassium channel blockers. Class IV antiarrhythmics--calcium channel blockers--are used when a group of reentrant arrhythmias arises in regions in which conduction is primarily sustained by increases in permeability to calcium ions. The mechanisms of action of antiarrhythmic agents are discussed with respect to the basic cellular mechanisms of cardiac arrhythmias.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias

